Clinical Trials in Philadelphia

Showing 16361-16380 of 20,904 trials

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

NCT01286753

This open-label, multi-center study will evaluate the safety and efficacy of Vemurafenib (RO5185426) in participants with metastatic or unresectable papillary thyroid cancer (PTC) positive for the BRAF V600 mutation and resistant to radioactive iodine therapy. Participants will receive vemurafenib 960 milligrams (mg) orally twice daily until progressive disease or unacceptable toxicity occurs.

Neoplasms

Hoffmann-La Roche51 participantsStarted Jun 2011

Torrance, California, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +13 more locations

COMPLETEDPhase 4< 1 mile

Bipolar Study in Adults at Least 18 Years of Age

NCT00067938

Bipolar study of tolerability, clinical response and patient satisfaction

Bipolar Disorder

GlaxoSmithKline1,200 participantsStarted Aug 2003

Albertville, Alabama, United States • Anniston, Alabama, United States • Birmingham, Alabama, United States +305 more locations

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Bipolar Study in Adults at Least 18 Years of Age

Find Trials by Condition in Philadelphia

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

School Breakfast Policy Initiative Study

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Triage-Based Application of OFAR on the Number of Radiographs Ordered

A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps

Robotic-assisted Versus Laparoscopic Sigmoid Resection

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Sensor Optimization of Cardiac Resynchronization Therapy Response